Ocuphire Pharma Results Presentation Deck

RM 10 Baseline Characteristics Study Eye (mITT Population) Treatment and Placebo Arms Were Balanced Across These Ocular Measurements Baseline Characteristic Baseline Pupil Diameter Mean (mm) Max Dilated Pupil Diameter Mean (mm) Accommodation Median (diopters) BCDVA letters 55 letters = 20/20 DCNVA letters 70 letters = 20/20 IOP (mmHg) Source: MIRA-2 TLR table #14.1.2.3 (mITT) Nyxol n=94 5.09 7.21 7.28 57 58 15.3 Placebo n=91 5.18 7.20 7.41 59 61 15.1 Total n=185 5.13 7.20 7.41 58 59 15.2 Ocuphire PHARMA

View entire presentation